Atreca to Present at Two Upcoming Virtual Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will participate in two upcoming investor conferences:
2020 Wedbush PacGrow Healthcare Virtual Conference
Wednesday, August 12, 2020
Presentation time: 2:20 p.m. EDT
Canaccord Genuity 40th Annual Growth Conference
Thursday, August 13, 2020
Presentation time: 4:00 p.m. EDT
Live webcasts of each event can be accessed through the Events & Presentations section of the Company's website at . Archived replays of the webcasts will be available on the Company's website for 90 days following the live presentations.
About Atreca, Inc.
Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for first-in-class therapeutic candidates, such as our lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients. For more information on Atreca, please visit .
Contacts
Atreca, Inc.
Herb Cross
Chief Financial Officer
Investors:
Alex Gray, 650-779-9251, ext. 251
Media:
Sheryl Seapy, 213-262-9390
Source: Atreca, Inc.
